4//SEC Filing
GOLDE DAVID 4
Accession 0001005477-04-000036
CIK 0000727510other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 3:45 PM ET
Size
8.1 KB
Accession
0001005477-04-000036
Insider Transaction Report
Form 4
GOLDE DAVID
Director
Transactions
- Award
Common Stock Right
2003-12-31+293→ 293 total→ Common Stock (293 underlying) - Award
Common Stock (right to buy)
2004-01-02+5,000→ 5,000 totalExercise: $12.15From: 2005-01-01Exp: 2014-01-01→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]Securities granted by Enzon Pharmaceuticals, Inc. pursuant to Enzon's 2001 Incentive Stock Plan as compensation for service as an Independent Director during the quarter ended December 31, 2003 and qualified under Rule 16b-3(d). The value of the compensation was $3,500. In the spring of 2004, each Common Stock Right will be exchanged for one share of Common Stock; provided, however, Dr. Golde will be entitled to elect to receive cash for up to 50% of these rights, with the price per right being $11.97, the fair market value of Enzon's Common Stock on December 31, 2003.
- [F2]Each Common Stock Right that is exchanged will be exchanged for one share of Enzon's Common Stock.
- [F3]Annual option granted to the Independent Directors of Enzon pursuant to Enzon’s 2001 Incentive Stock Plan and qualified under Rule 16b-3(d).
Documents
Issuer
ENZON PHARMACEUTICALS INC
CIK 0000727510
Entity typeother
Related Parties
1- filerCIK 0001058148
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 3:45 PM ET
- Size
- 8.1 KB